Kynam Capital Management LP 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:18 pm Purchase | 2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Kynam Capital Management LP | 8,520,000 9.980% | 2,860,000 (+50.53%) | Filing |
| 2024-02-14 12:50 pm Purchase | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Kynam Capital Management LP | 5,660,000 6.670% | 5,660,000 (New Position) | Filing |